ebola whole-virus vaccine protective nonhuman primates 
zaire ebolavirus causative agent current outbreak hemorrhagic fever disease west africa previously showed whole ebola virus ebov vaccine based replication-defective ebov ebov delta vp30 protects immunized mice guinea pigs lethal challenge rodent-adapted ebov demonstrate ebov delta vp30 protects nonhuman primates lethal infection ebov although ebov delta vp30 replication-incompetent additionally inactivated vaccine hydrogen peroxide; chemically inactivated vaccine remained antigenic protective nonhuman primates ebov delta vp30 thus represents safe efficacious whole-ebov vaccine candidate differs ebov vaccine platforms presents viral proteins viral rna host immune system might contribute protective immune responses 
